VYNE Therapeutics Inc. (VYNE) Financials
VYNE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 97.7 million | 9.0 million |
2023-09-30 | 19.3 million | 7.8 million |
2023-06-30 | 25.0 million | 7.7 million |
2023-03-31 | 35.3 million | 8.8 million |
VYNE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -5.1 million | 710000 |
2023-09-30 | -5.2 million | 863000 |
2023-06-30 | -9.6 million | 876000 |
2023-03-31 | -5.5 million | 856000 |
VYNE Net Income
No data available :(
VYNE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 93.3 million | - | 214000 |
2023-09-30 | 15.4 million | - | - |
2023-06-30 | 20.6 million | - | - |
2023-03-31 | 30.2 million | - | - |
VYNE Shares Outstanding
VYNE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 3.0 million | 13.4 million | 9.5 million |
2023-09-30 | - | 3.3 million | 3.0 million | - |
2023-06-30 | - | 7.2 million | 3.2 million | - |
2023-03-31 | - | 2.7 million | 3.2 million | - |
VYNE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 76000 | - |
2023-09-30 | 114000 | - |
2023-06-30 | 135000 | - |
2023-03-31 | 99000 | - |
VYNE
Price: $2.53
52 week price:
Earnings Per Share: -2.72 USD
P/E Ratio: -0.23
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 68900
Market Capitalization: 39.1 million